Browse by Audience
Skip to content
Papers of the Week
Targeting FAP-positive chondrocytes in osteoarthritis: a novel lipid nanoparticle siRNA approach to mitigate cartilage degeneration.
Authors
Zhao X, Lin J, Liu M, Jiang D, Zhang Y, Li X, Shi B, Jiang J, Ma C, Shao H, Xu Q, Ping H, Li J, Gao YAbstract
Osteoarthritis (OA) is a common joint disease that leads to chronic pain and functional limitations. Recent research has revealed soluble fibroblast activation protein (FAP) secreted from OA synovium could degrade type II collagen (Col2) in cartilage to promote the progression of OA. This study aimed to reveal the role of FAP from chondrocytes in OA and develop a novel lipid nanoparticle (LNP)-FAP siRNA delivery system for OA treatment.